•
Shenzhen GeneBioHealth Co., Ltd, a China-based in-vitro diagnostic (IVD) medical device developer, has reportedly raised USD 15 million in a Series B+ financing round. The funds will be used to support bio-business development and product pipeline research and development (R&D). This investment underscores the company’s commitment to advancing its diagnostic…